Nuveen Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$5.74M Sell
434,058
-25,474
-6% -$337K ﹤0.01% 1920
2024
Q3
$8.85M Sell
459,532
-96,882
-17% -$1.86M ﹤0.01% 1688
2024
Q2
$11.4M Buy
556,414
+163,728
+42% +$3.36M ﹤0.01% 1501
2024
Q1
$9.35M Sell
392,686
-231,324
-37% -$5.51M ﹤0.01% 1636
2023
Q4
$13.5M Buy
624,010
+450,571
+260% +$9.74M ﹤0.01% 1396
2023
Q3
$2.52M Buy
173,439
+12,492
+8% +$181K ﹤0.01% 2207
2023
Q2
$3.37M Buy
160,947
+9,710
+6% +$203K ﹤0.01% 2098
2023
Q1
$3.19M Buy
151,237
+6,375
+4% +$135K ﹤0.01% 2131
2022
Q4
$3.69M Sell
144,862
-21,015
-13% -$535K ﹤0.01% 2087
2022
Q3
$3.99M Buy
165,877
+35
+0% +$841 ﹤0.01% 2030
2022
Q2
$3.19M Buy
165,842
+2,252
+1% +$43.3K ﹤0.01% 2195
2022
Q1
$2.77M Sell
163,590
-271
-0.2% -$4.59K ﹤0.01% 2364
2021
Q4
$2.93M Sell
163,861
-10,809
-6% -$193K ﹤0.01% 2379
2021
Q3
$3.46M Sell
174,670
-42,244
-19% -$836K ﹤0.01% 2415
2021
Q2
$3.73M Buy
216,914
+78,723
+57% +$1.35M ﹤0.01% 2396
2021
Q1
$3.09M Sell
138,191
-18,147
-12% -$406K ﹤0.01% 2407
2020
Q4
$3.48M Sell
156,338
-30,303
-16% -$674K ﹤0.01% 2250
2020
Q3
$2.76M Buy
186,641
+69,338
+59% +$1.02M ﹤0.01% 2223
2020
Q2
$1.74M Buy
117,303
+42,266
+56% +$627K ﹤0.01% 2400
2020
Q1
$824K Sell
75,037
-14,119
-16% -$155K ﹤0.01% 2596
2019
Q4
$783K Sell
89,156
-59,832
-40% -$525K ﹤0.01% 2773
2019
Q3
$1.11M Buy
148,988
+39,756
+36% +$297K ﹤0.01% 2656
2019
Q2
$1.02M Buy
+109,232
New +$1.02M ﹤0.01% 2727